Clinical Trial Update: Long-term Impact of Pneumococcal Conjugate Vaccine on Carriage

View source ↗

Summary

A completed clinical trial examining the long-term impact of pneumococcal conjugate vaccine on nasopharyngeal carriage of pneumococcus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumococcal Infections

Drugs mentioned

• Prevnar (pneumococcal conjugate vaccine)

Snippet

Sponsor: Johns Hopkins Bloomberg School of Public Health | Conditions: Pneumococcal Infections | Status: COMPLETED